The third edition of NZ Drug Foundation annual report on how New Zealand is dealing with alcohol and other drugs was published in December 2020.
The aim of State of the Nation is to provide a backdrop against which we can assess the impact...
The Global Synthetic Drugs Assessment 2020 provides an analysis of the global synthetic drugs market.
The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health and relationships.
Ov...
In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe.
The journey begins with the first report describing the drug situation in 1995 and leads us, over...
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug...
Tobacco, alcohol and illicit drug use can place a heavy burden on individuals, families and society. The health,
social and economic effects are diverse and substantial, and include disease and injury, mental health
conditions...
The aim of this paper is to analyse changes in alcohol consumption since the spread of the COVID-19 pandemic.
We show that the frequency of alcohol consumption during COVID-19 is slightly higher for males than it was 2-3 years previously...
"Of all the lifestyle choices we make in conjunction with pregnancy, none are of greater importance to the child’s future health and development than the ones we make in relation to alcohol."
Alcohol, pregnancy and infant health – a shared...
Noncommunicable diseases are the leading cause of premature death globally.
Every year, 41 million people die from heart attacks, stroke, cancer, chronic respiratory diseases, diabetes or a mental disorder.
Despite the concerning trends...
The Nordic Alcohol and Drug Policy Network (NordAN) was established in September 2000 as a network of non-governmental, voluntary organisations. Their aim is to reduce the consumption of alcohol and other drugs and support restrictive...
This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe.
Almost 24,000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years...
The rise in alcohol consumption and alcohol-related harms in the UK in recent decades has gone hand in hand with the increasing affordability of alcoholic beverages.
Minimum Unit Pricing (setting a minimum price below which a unit of...
The consumption of alcohol, tobacco and other drugs is a significant cause of preventable disease and illness in Australia. There is a wide range of data sources available that contribute to our understanding of alcohol, tobacco and...
On 16 September 2014, European Union (EU) the Member States, represented by the Committee on National Alcohol Policy and Action (CNAPA), endorsed the Action Plan on Youth Drinking and on Heavy Episodic Drinking (Binge Drinking) (2014-2016)...
